| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.234.416 | 9.301.848 | 8.809.470 | 7.997.474 | 12.053.766 | 11.113.205 | 10.167.882 | 11.959.622 | 13.108.232 | 14.458.288 |
| Total Income - EUR | 9.507.674 | 9.524.187 | 9.561.183 | 8.224.482 | 12.906.249 | 12.298.336 | 10.993.885 | 13.274.233 | 14.492.568 | 15.271.626 |
| Total Expenses - EUR | 8.676.182 | 8.649.790 | 7.711.112 | 7.109.140 | 11.036.439 | 9.663.748 | 8.854.646 | 10.493.129 | 11.960.432 | 14.396.148 |
| Gross Profit/Loss - EUR | 831.492 | 874.398 | 1.850.070 | 1.115.343 | 1.869.810 | 2.634.588 | 2.139.239 | 2.781.104 | 2.532.135 | 875.478 |
| Net Profit/Loss - EUR | 721.797 | 751.483 | 1.322.686 | 948.239 | 1.613.731 | 2.278.894 | 1.877.490 | 2.391.328 | 2.328.978 | 757.954 |
| Employees | 45 | 47 | 50 | 51 | 50 | 49 | 51 | 50 | 50 | 54 |
Check the financial reports for the company - Three Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.459.443 | 10.750.341 | 11.048.030 | 10.748.158 | 10.122.657 | 9.405.599 | 8.613.814 | 9.085.945 | 9.210.587 | 16.453.124 |
| Current Assets | 4.019.258 | 3.648.100 | 4.066.166 | 3.331.603 | 4.118.718 | 4.384.908 | 4.992.431 | 7.361.097 | 5.704.441 | 3.822.701 |
| Inventories | 1.376.764 | 1.347.462 | 1.362.866 | 2.152.871 | 2.262.463 | 1.734.149 | 1.877.336 | 2.890.023 | 2.087.558 | 2.100.850 |
| Receivables | 2.755.034 | 2.091.838 | 2.815.513 | 1.461.651 | 1.510.937 | 2.092.715 | 1.827.639 | 2.531.446 | 2.896.096 | 3.277.190 |
| Cash | -112.540 | 150.655 | -112.213 | -282.920 | -367.040 | 221.860 | 408.317 | 181.660 | 439.471 | -1.555.339 |
| Shareholders Funds | 2.742.796 | 1.786.616 | 3.079.069 | 3.541.018 | 4.553.802 | 6.224.088 | 6.743.785 | 5.493.495 | 7.531.136 | 7.010.778 |
| Social Capital | 495.588 | 490.534 | 482.233 | 473.383 | 464.216 | 455.415 | 445.316 | 446.698 | 445.343 | 442.854 |
| Debts | 7.735.641 | 12.659.786 | 12.069.405 | 10.590.570 | 9.728.653 | 7.588.091 | 6.863.558 | 10.975.817 | 7.394.920 | 13.324.399 |
| Income in Advance | 45.309 | 38.582 | 31.771 | 25.142 | 20.999 | 27.174 | 34.103 | 27.486 | 23.007 | 18.655 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Three Pharm Srl